Evidence map›Paper›PMID 40372995›Full record

ArticlePloS one2025

Investigating the Key Trends in Applying Artificial Intelligence to Health Technologies: A Scoping Review.

Tawil Samah, Merhi Samar

Abstract readScoping Review
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tawil SamahGilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-2980-9933
Merhi SamarFaculty of Nursing and Health Sciences, Notre Dame University-Louaize (NDU), Zouk Mosbeh, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of Artificial Intelligence (AI) is exponentially rising in the healthcare sector. This change influences various domains of early identification, diagnosis, and treatment of diseases. PURPOSE: This study examines the integration of AI in healthcare, focusing on its transformative potential in diagnostics and treatment, and the challenges and methodologies. shaping its future development.

methodsThe review included 68 academic studies retracted from different databases (WOS, Scopus and Pubmed) from January 2020 and April 2024. After careful review and data analysis, AI methodologies, benefits and challenges, were summarized.

resultsThe number of studies showed a steady rise from 2020 to 2023. Most of them were the results of a collaborative work with international universities (92.1%). The majority (66.7%) were published in top-tier (Q1) journals and 40% were cited 2-10 times. The results have shown that AI tools such as deep learning methods and machine learning continue to significantly improve accuracy and timely execution of medical processes. Benefits were discussed from both the organizational and the patient perspective in the categories of diagnosis, treatment, consultation and health monitoring of diseases. However, some challenges may exist, despite these benefits, and are related to data integration, errors related to data processing and decision making, and patient safety.

conclusionThe article examines the present status of AI in medical applications and explores its potential future applications. The findings of this review are useful for healthcare professionals to acquire deeper knowledge on the use of medical AI from design to implementation stage. However, a thorough assessment is essential to gather more insights into whether AI benefits outweigh its risks. Additionally, ethical and privacy issues need careful consideration.

Indexed as

Artificial IntelligenceBiomedical TechnologyDeep LearningDelivery of Health CareHumansMachine Learning

Identifiers

PMID40372995
PMCPMC12080793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.